Medical Journals

Cytokines Produced by Bone Marrow Cells Can Contribute to Functional Improvement of the Infarcted Heart by Protecting Cardiomyocytes from Ischemic Injury.

Authors:
  • Takahashi Masaya
  • Li Tao-Sheng
  • Suzuki Ryo
  • Kobayashi Toshiro
  • Ito Hiroshi
  • Ikeda Yasuhiro
  • Matsuzaki Masunori
  • Hamano Kimikazu

From: Department of Medical Bioregulation, Division of Cardiovascular Surgery and Medicine, Yamaguchi University School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan.

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Aug 2006
  • ISSN: 0363-6135
  • Volume: 291
  • Issue: 2
  • Pages: H886-93
  • Medium: Print
  • Language: English
  • Citation (JAMA): Takahashi Masaya, Li Tao-Sheng, Suzuki Ryo, et al. Cytokines Produced by Bone Marrow Cells Can Contribute to Functional Improvement of the Infarcted Heart by Protecting Cardiomyocytes from Ischemic Injury.. Am. J. Physiol. Heart Circ. Physiol. Aug 2006;291:H886-93

Abstract

It is well known that the implantation of bone marrow mononuclear cells (BM-MNCs) into ischemic hearts can induce angiogenesis and improve cardiac function after myocardial infarction, but the precise mechanisms of these actions are unclear. We hypothesize that the cytokines produced by BM-MNCs play a key role in this cell-based therapy. BM-MNCs from rats were cultured under normoxic or hypoxic (1% O2) conditions for 24 h, and then supernatants were collected for study. ELISA and Western blotting analysis showed that various cytokines, including VEGF, IL-1 beta, PDGF, and IGF-1, were produced from BM-MNCs, some of which were enhanced significantly under hypoxia stimulation. When compared with a control blank medium, the supernatants of BM-MNCs cultured under normoxic or hypoxic conditions inhibited apoptosis significantly and preserved the contractile capacity of isolated adult rat cardiomyocytes in vitro (P < 0.05). Using a rat model of acute myocardial infarction, we injected the supernatants of BM-MNCs or control medium intramyocardially on day 0 and then intraperitoneally on days 2, 4, and 6 after infarction. When compared with the control medium, the supernatants of BM-MNCs cultured under both normoxic or hypoxic conditions increased the microvessel density and decreased the fibrotic area in the infarcted myocardium significantly, contributing to remarkable improvement in cardiac function. Various cytokines were produced by BM-MNCs, and these cytokines contributed to functional improvement of the infarcted heart by directly preserving the contractile capacity of the myocardium, inhibiting apoptosis of cardiomyocytes, and inducing therapeutic angiogenesis of the infarcted heart.

Mesh Headings (Keywords): Acute Disease, Animals, Apoptosis, Blotting, Western, Bone Marrow Cells, Calcium Signaling, Cell Hypoxia, Cell Proliferation, Cells, Cultured, Cytokines, Echocardiography, Endothelial Cells, Enzyme-Linked Immunosorbent Assay, Male, Myocardial Contraction, Myocardial Infarction, Myocardial Ischemia, Myocytes, Cardiac, Neovascularization, Physiologic, Rats, Rats, Wistar


Check for Full Text / PubMed Unique Identifier (PMID): 16603697


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.